Aliri Bioanalysis scientists at our Colorado Springs lab recently developed and validated an enzyme activity assay for ornithine transcarbamylase (OTC) in human plasma by taking advantage of mass spectrometry’s unique mass-resolving power. This work used human plasma in lieu of tissue biopsies for activity assessments and suggested that OTC activity in plasma could be used as a pharmacodynamic endpoint for OTC Deficiency treatment.
Download our poster to learn more.